We are live on ! Find out more
FGP

Freestone Grove Partners Portfolio holdings

AUM $15.6B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+14.49%
1 Year Est. Return
+27.39%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$15.6B
AUM Growth
+$1.42B
Cap. Flow
+$81.1M
Cap. Flow %
0.52%
Top 10 Hldgs %
22.3%
Holding
1,397
New
435
Increased
253
Reduced
266
Closed
407

Sector Composition

Rank Sector Weight
1 Industrials 19.5%
2 Financials 16.81%
3 Miscellaneous 15.64%
4 Technology 13.57%
5 Healthcare 10.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSTR icon
776
Strategy Inc
MSTR
$56.7B
$267K ﹤0.01%
+3,069
New +$445K
JOE icon
777
St. Joe Company
JOE
$3.76B
$266K ﹤0.01%
+4,253
New +$279K
RPRX icon
778
Royalty Pharma
RPRX
$28.5B
$262K ﹤0.01%
4,670
-611,707
-99% -$31.8M
CRMD icon
779
CorMedix
CRMD
$657M
$262K ﹤0.01%
33,335
+23,003
+223% +$182K
BCC icon
780
Boise Cascade
BCC
$2.76B
$257K ﹤0.01%
3,310
-319
-9% -$23.6K
IIPR icon
781
Innovative Industrial Properties
IIPR
$1.58B
$252K ﹤0.01%
4,067
+3,419
+528% +$192K
FSS icon
782
Federal Signal
FSS
$7.28B
$248K ﹤0.01%
1,929
+1,552
+412% +$178K
NVAX icon
783
Novavax
NVAX
$1.69B
$247K ﹤0.01%
26,223
-1,953
-7% -$17.5K
TVTX icon
784
Travere Therapeutics
TVTX
$6.15B
$244K ﹤0.01%
4,294
+570
+15% +$25.3K
TMDX icon
785
Transmedics
TMDX
$3.12B
$235K ﹤0.01%
+3,537
New +$299K
ACLS icon
786
Axcelis
ACLS
$3.55B
$233K ﹤0.01%
1,228
-5,789
-82% -$859K
NBTB icon
787
NBT Bancorp
NBTB
$2.72B
$215K ﹤0.01%
+4,357
New +$199K
SATL icon
788
Satellogic
SATL
$713M
$214K ﹤0.01%
+37,398
New +$274K
BOOT icon
789
Boot Barn
BOOT
$4.67B
$211K ﹤0.01%
1,286
-121,045
-99% -$19.6M
BXMT icon
790
Blackstone Mortgage Trust
BXMT
$2.39B
$210K ﹤0.01%
+12,388
New +$231K
UTZ icon
791
Utz Brands
UTZ
$1.26B
$207K ﹤0.01%
26,900
-73,698
-73% -$550K
CHRW icon
792
C.H. Robinson
CHRW
$17.3B
$203K ﹤0.01%
1,080
+1,067
+8,208% +$190K
HPE icon
793
Hewlett Packard
HPE
$69B
$199K ﹤0.01%
4,420
-709,162
-99% -$25.6M
BILI icon
794
Bilibili
BILI
$6.37B
$198K ﹤0.01%
+11,612
New +$235K
AHCO icon
795
AdaptHealth
AHCO
$866M
$196K ﹤0.01%
+18,844
New +$210K
WINA icon
796
Winmark
WINA
$1.14B
$194K ﹤0.01%
459
+120
+35% +$46.9K
DCH
797
Dauch Corp
DCH
$1.66B
$194K ﹤0.01%
+35,784
New +$217K
AEHR icon
798
Aehr Test Systems
AEHR
$2.81B
$189K ﹤0.01%
+1,970
New +$180K
FTDR icon
799
Frontdoor
FTDR
$5.69B
$188K ﹤0.01%
2,425
-3,055
-56% -$195K
BBIO icon
800
BridgeBio Pharma
BBIO
$14.6B
$188K ﹤0.01%
+2,524
New +$177K

Similar funds

Freestone Grove Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Freestone Grove Partners held 1,397 positions worth $15.6B, up 10% from $14.2B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Freestone Grove Partners's Q2 2026 filing shows 435 new, 253 increased, 266 reduced and 407 closed positions. Its largest new stake was Abbott: 1,372,846 shares worth $125M. The largest sale was Datadog, an estimated $128M.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, up from 12% a quarter earlier, followed by Financials and Miscellaneous.

  • Freestone Grove Partners's largest Q2 2026 buy was Abbott: 1,372,846 shares worth $125M.
  • Freestone Grove Partners added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $311M increase.
  • Freestone Grove Partners's biggest Q2 2026 reduction was Elastic, cutting an estimated $110M.
  • Freestone Grove Partners fully exited Datadog in Q2 2026, selling an estimated $128M.
  • Freestone Grove Partners's ten largest holdings make up 22% of its $15.6B portfolio in Q2 2026.
  • Freestone Grove Partners opened 435 new positions and closed 407 in Q2 2026.
  • Freestone Grove Partners's portfolio value rose 10% quarter-over-quarter to $15.6B.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.